Valuation: GC Genome Corporation

Market Cap 229B 173M 155M 143M 129M 242M 16.44B 246M 1.72B 681M 8.61B 650M 636M 27.15B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 170M 128K 115K 106K 95.94K 179K 12.18M 182K 1.27M 504K 6.38M 482K 471K 20.12M EV / Sales 2026 *
4.36x
EV / Sales 2027 * 3.29x
Free-Float
49.55%
Yield 2026 *
-
Yield 2027 * -
1 day-3.39%
1 week+5.09%
Current month+12.01%
1 month+18.58%
3 months+90.94%
6 months+18.73%
Current year+42.23%
1 week 8,720
Extreme 8720
10,350
1 month 8,120
Extreme 8120
10,480
Current year 4,100
Extreme 4100
10,480
1 year 4,100
Extreme 4100
10,480
3 years 4,100
Extreme 4100
15,180
5 years 4,100
Extreme 4100
15,180
10 years 4,100
Extreme 4100
15,180
Manager TitleAgeSince
Chief Executive Officer 57 2020-03-25
Director of Finance/CFO 50 2025-03-26
Comptroller/Controller/Auditor 45 2024-03-28
Director TitleAgeSince
Director/Board Member 57 2023-03-29
Date Insider Type Main position Quantity % Market Cap. Importance
6/17/25 Free

Chief Executive Officer

169,285 -
6/17/25 Free 138,250 --
Change 5-day change 1-year change 3-year change Capi.($)
-3.39%+5.09%+33.24% - 173M
-1.07%+1.20%+14.09%+35.52% 120B
+0.37%+2.22%+4.92%+103.82% 102B
+0.64%+2.67%+109.83%+890.32% 58.23B
+1.75%+2.27%-5.92%+83.08% 29.08B
-0.57%+2.93%+32.78%+95.74% 26.61B
-0.30%+3.46%+17.70%+65.59% 26.68B
-0.81%+0.45%+27.60%+378.95% 21.62B
+0.67%-4.91%-23.01%-9.01% 19.58B
-0.68%+2.72%+3.48%+85.69% 18.93B
Average -0.35%+1.19%+21.47%+192.19% 42.2B
Weighted average by Cap. -0.11%+1.65%+23.62%+196.73%

Financials

2026 *2027 *
Net sales 39B 29.44M 26.29M 24.29M 22.01M 41.18M 2.79B 41.86M 292M 116M 1.46B 110M 108M 4.62B 48.8B 36.84M 32.9M 30.39M 27.54M 51.52M 3.5B 52.37M 366M 145M 1.83B 138M 135M 5.78B
Net income - -
Net Debt -59.4B -44.84M -40.04M -36.99M -33.52M -62.71M -4.26B -63.75M -445M -176M -2.23B -168M -165M -7.03B -68.8B -51.93M -46.38M -42.84M -38.83M -72.64M -4.93B -73.84M -516M -204M -2.58B -195M -191M -8.14B
Projected Income Statement - Annual - GC Genome Corporation
Logo GC Genome Corporation
GC Genome Corp is a Korea-based company principally engaged in the provision of genome testing and analysis services. The Company is principally engaged in the provision of prenatal and newborn screening genetic testing services, cancer patient precision diagnosis genetic testing services, precision diagnosis genetic testing service for patients with rare diseases, health checkup test services as well as others.
Employees
-
Date Price Change Volume
26-10-23 ₩9,700.00 -3.39% 687,441
26-10-22 ₩10,040.00 +1.11% 907,081
26-10-21 ₩9,930.00 -3.12% 580,228
26-10-20 ₩10,250.00 +9.63% 1,467,784
26-10-19 ₩9,350.00 +1.30% 703,731

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - GC Genome Corporation
  1. Stock Market
  2. Stocks
  3. A340450 Stock